| Malignant Appendix Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived27 of 27show fewer |
|---|
| → investigated in trials for | Mitomycinsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |